Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-31

Clinical Trial Update: A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Sativex® in pain relief due to diabetic neuropathy has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Pain, Diabetic Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2012-07-31